Software

AI for digital pathology and spatial biology

Katana Labs GmbH

Katana Labs is revolutionizing image-based analysis of tumor tissues using artificial intelligence. Its cloud-based platform PAIKON enables pathologists to visualize and analyse upto a million cells in giga-pixel histopathology images with ease. PAIKON assists in the assessment of multiple cancer entities across various image modalities, enabling the next step in precision medicine.

Katana Labs provides products and services for clinical diagnostics and R&D in the biotech and pharmaceutical industries. Building on expertise in digital pathology, image analysis and AI, the company provides the best algorithms for routine diagnostic tests and facilitates analysis in Spatial Omics for the development of new biomarkers.

TGFS has been involved with the company since 2023.

Status
Active

Segment
Early stage

Headquarter
Dresden

Website
www.katana-labs.com

TGFS-Team
Christian John
Tobias Voigt

Company news

Neu im Portfolio: Katana Labs GmbH

8. Nov. 2023

Dem Krebs auf der Spur – die Software von Katana Labs erkennt Krebszellen mit Künstlicher Intelligenz. Damit die Analyse-Software weiterentwickelt, zertifiziert und in Laboren weltweit Anwendung finden kann, investierte der TGFS in der Pre-Seed-Phase in das Unternehmen aus Dresden.